A4N
Click for more information
0.84% 90.3¢ alpha hpa limited

Ann: HPA First Project Update, page-74

 

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
watchlist Created with Sketch. Add A4N (ASX) to my watchlist
(20min delay)
Last
90.3¢ 		Change
0.008(0.84%) 		Mkt cap ! $1.023B
Open High Low Value Volume
88.5¢ 90.5¢ 88.0¢ $1.101M 1.231M

Buyers (Bids)

No. Vol. Price($)
11 20748 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
90.5¢ 60224 31
View Market Depth
Last trade - 15.45pm 02/07/2024 (20 minute delay) ?
A4N (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.